http://www.unboundmedicine.com/medline/ebm/research/candesartanUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19890371/full_citation/Effects_of_losartan_vs_candesartan_in_reducing_cardiovascular_events_in_the_primary_treatment_of_hypertension_Kjeldsen SE, Stålhammar J, Hasvold P, et al. 
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. [JOURNAL ARTICLE]
J Hum Hypertens 2009 Nov 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19887503/full_citation/Candesartan_improves_blood_pressure_control_and_reduces_proteinuria_in_renal_transplant_recipients:_results_from_SECRET_Philipp T, Martinez F, Geiger H, et al. 
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. [JOURNAL ARTICLE]
Nephrol Dial Transplant 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19886856/full_citation/Spironolactone_and_Chlorthalidone_in_Uncontrolled_Elderly_Hypertensive_Patients_Treated_with_Calcium_Antagonists_and_Angiotensin_II_Receptor_Blocker:_Effects_on_Endothelial_Function_Inflammation_and_Oxidative_Stress_Yamanari H, Nakamura K, Miura D, et al. 
Spironolactone and Chlorthalidone in Uncontrolled Elderly Hypertensive Patients Treated with Calcium Antagonists and Angiotensin II Receptor-Blocker: Effects on Endothelial Function, Inflammation, and Oxidative Stress. [Journal Article]
Clin Exp Hypertens 2009 Oct; 31(7):585-94.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881223/full_citation/Constitutively_Active_Mutant_N111G_of_Angiotensin_II_Type_1__AT_1___Receptor_Induces_Homologous_Internalization_Through_Mediation_of_AT_1__Receptor_Antagonist_Bhuiyan MA, Hossain M, Miura SI, et al. 
Constitutively Active Mutant N111G of Angiotensin II Type 1 (AT(1)) Receptor Induces Homologous Internalization Through Mediation of AT(1)-Receptor Antagonist. [JOURNAL ARTICLE]
J Pharmacol Sci 2009 Oct 31.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19879152/full_citation/Novel_O_[_11_C]methylated_derivatives_of_candesartan_as_angiotensin_II_AT_1__receptor_imaging_ligands:_Radiosynthesis_and_ex_vivo_evaluation_in_rats_Hadizad T, Kirkpatrick SA, Mason S, et al. 
Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: Radiosynthesis and ex vivo evaluation in rats. [JOURNAL ARTICLE]
Bioorg Med Chem 2009 Oct 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19864959/full_citation/Potentiation_by_candesartan_of_protective_effects_of_pioglitazone_against_type_2_diabetic_cardiovascular_and_renal_complications_in_obese_mice_Fukuda M, Nakamura T, Kataoka K, et al. 
Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice. [JOURNAL ARTICLE]
J Hypertens 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860206/full_citation/[Evaluation_of_antihypertensive_effect_of_angiotensin_II_receptor_blockers_in_patients_with_essential_hypertension_by_self_measured_home_blood_pressure__HACARARE_300_study]Msanobu T 
[Evaluation of antihypertensive effect of angiotensin II receptor blockers in patients with essential hypertension by self-measured home blood pressure--HACARARE 300 study] [English Abstract, Journal Article]
Nippon Rinsho 2009 Oct; 67(10):2013-20.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19845401/full_citation/Angiotensin_AT1_receptor_antagonism_ameliorates_murine_retinal_proteome_changes_induced_by_diabetes_Gao BB, Phipps JA, Bursell D, et al. 
Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes. [JOURNAL ARTICLE]
J Proteome Res 2009 Oct 21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19829095/full_citation/Modulation_of_Advanced_Glycation_End_Products_by_Candesartan_in_Patients_with_Diabetic_Kidney_Disease_A_Dose_Response_Relationship_Study_Saha SA, Lasalle BK, Clifton GD, et al. 
Modulation of Advanced Glycation End Products by Candesartan in Patients with Diabetic Kidney Disease-A Dose-Response Relationship Study. [JOURNAL ARTICLE]
Am J Ther 2009 Oct 13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19828927/full_citation/Pharmacological_and_clinical_properties_of_ECARD__R___combination_tablets_LD_&_HD_fixed_dose_combination_of_candesartan_cilexetil_and_hydrochlorothiazide_Kusumoto K, Mori M, Tanokashira J, et al. 
Pharmacological and clinical properties of ECARD((R)) combination tablets LD & HD, fixed-dose combination of candesartan cilexetil and hydrochlorothiazide. [Journal Article]
Nippon Yakurigaku Zasshi 2009 Oct; 134(4):217-24.
Full Citation